Company: RPTX
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001193125-25-284040
Chunk: 15

Company: Repare Therapeutics Inc.
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 15
---
 Security Act of 1974, as amended (“ERISA”); |

| (cc) | “COBRA Costs” means an amount in cash equal to the aggregate employer-side share of all                                                                                                                                                                  
 premiums, administrative fees, excise taxes, penalties, assessments and any other costs that are reasonably anticipated to become due and payable, from and after the Effective Date through the latest date on which any Qualified Beneficiary (as such 
 term is defined in Section 4980B of the Code and Sections 601-609 of ERISA) could elect or remain entitled to continuation coverage under any group health plan maintained by the Company or any person that                                             
 would be treated as a single employer with the Company or part of the same “controlled group” as such Entity under Sections 414(b),(c),(m) or (o) of the Code with respect to any current or former employee (or any spouse, dependent                   
 or other qualified beneficiary thereof) whose qualifying event occurs on or prior to the Effective Date;                                                                                                                                                 |

| (dd) | “Code” means the U.S. Internal Revenue Code of 1986, as amended; |

| (ee) | “Common Shares” means the common shares in the capital of the Company; |

| (ff) | “Company” has the meaning set out in the recitals; |

| (gg) | “Company Assets” means all of the assets (tangible and intangible), properties (real or                                                                                                                    
 personal) and equipment (including all attachments, accessories and all other items required for the operation thereof) owned, leased or otherwise used or held for use by the Company and its Subsidiary; |

| (hh) | “Company Outstanding Shares” means the total number of issued and outstanding Common Shares                                                                      
 at the Effective Time, on a partially diluted basis taking into account the Common Shares issuable upon exercise of all Options and upon settlement of all RSUs; |

| (jj) | “Consideration” means, per Common Share, the aggregate cash amount payable by the Company 
 pursuant to the Distribution plus one CVR issuable by the Purchaser;                      |

| (kk) | “Constating Documents” means notice of articles, articles of incorporation,                                                                                                          
 amalgamation, arrangement or continuation, as applicable, articles, by-laws, limited liability company operating agreement or other constating documents and all amendments thereto; |

| (ll) | “Contemplated Transactions” means (i) the Discontinu